Investing Profile

John McKearn

InvestorVC

Managing Director at RiverVest Venture Partners

Your Intro Paths to John McKearn

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks John is a member of

University of Chicago Network

109 CONNECTIONS

Pfizer Network

53 CONNECTIONS

Find John McKearn on

Current Investing Position

Investment Range

$100K - $10.0M

Sweet Spot

$1M

Investments On Record

John McKearn is on these Sector & Stage Rankings

John McKearn's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Allotera Therapeutics	Series CAug 2025$120M Series BJul 2021$170M	$290M
Co-investors: Niall O’Donnell (RiverVest), Bali Muralidhar (Abingworth)
OncoResponse	Series DMay 2023$14M	$110M
Co-investors: Wende Hutton (Canaan Partners)
Bonum Therapeutics	Series ANov 2022$93M	$93M
Co-investors: Karl Handelsman (Codon Capital), Samuel Bjork (Digitalis Ventures), Monique Schiersing (Roche Venture Fund)
Good Therapeutics	Series BDec 2021$8M Series AFeb 2019$11M	$30M
Co-investors: Karl Handelsman (Codon Capital), Samuel Bjork (Digitalis Ventures), Monique Schiersing (Roche Venture Fund)
Arch Oncology	Series CApr 2021$110M Series AAug 2016$86M	$190M
Co-investors: Peter Moldt (Novo Ventures), Carole Nuechterlein (F.Hoffmann-La Roche), Jill carroll (SR One)
Allakos	Series BDec 2017$100M Series ASep 2014$10M Series AAug 2014$25M	$290M
Co-investors: Farah Champsi (Alta Partners), Paul Walker (Unknown Ventures)
Otonomy	Series DApr 2014$49M Series CSep 2013$46M Series BAug 2010$39M Series BAug 2010$39M	$180M
Co-investors: Chau Khuong (OrbiMed), Brian Dovey (Domain Associates), Niall O’Donnell (RiverVest), Jay Lichter (Avalon Ventures), Peter Bisgaard (Pivotal bioVenture Partners), Bill Harrington (Osage University Partners (OUP)), Heather Preston
ZS Pharma	Series DMar 2014$55M Series COct 2012$46M	$100M